Evidence map›Paper›PMID 28607509›Full record

ArticleThe pharmacogenomics journal2018

Genetic background influences susceptibility to chemotherapy-induced hematotoxicity.

D M Gatti, S N Weber, N C Goodwin, F Lammert, G A Churchill

Abstract read
In one paragraph

Article in The pharmacogenomics journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Fifteen years of the Diversity Outbred mouse model: a review.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Role ofInternational journal of molecular sciences · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Animal models of endocrine disruption.Best practice & research. Clinical endocrinology & metabolism · 2018
    Review
  18. Genome-wide association for testis weight in the diversity outbred mouse population.Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

D M GattiThe Jackson Laboratory, Bar Harbor, ME, USA.
S N WeberSaarland University Medical Center, Homburg, Germany.
N C GoodwinThe Jackson Laboratory, Bar Harbor, ME, USA.
F LammertSaarland University Medical Center, Homburg, Germany.
G A ChurchillThe Jackson Laboratory, Bar Harbor, ME, USA.
Jackson Laboratory · USSaarland University · DE

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Systems Genetic Analysis of Multi-parent CrossesR01GM070683 · NIGMS · JACKSON LABORATORY · PI BROMAN, KARL W, CHURCHILL, GARY A · 2004 to 2022
$6.8M
NCI NIH HHS P30 CA034196NIGMS NIH HHS R01 GM070683
6 · The paper itself

Abstract

Hematotoxicity is a life-threatening side effect of many chemotherapy regimens. Although clinical factors influence patient responses, genetic factors may also play an important role. We sought to identify genomic loci that influence chemotherapy-induced hematotoxicity by dosing Diversity Outbred mice with one of three chemotherapy drugs; doxorubicin, cyclophosphamide or docetaxel. We observed that each drug had a distinct effect on both the changes in blood cell subpopulations and the underlying genetic architecture of hematotoxicity. For doxorubicin, we mapped the change in cell counts before and after dosing and found that alleles of ATP-binding cassette B1B (Abcb1b) on chromosome 5 influence all cell populations. For cyclophosphamide and docetaxel, we found that each cell population was influenced by distinct loci, none of which overlapped between drugs. These results suggest that susceptibility to chemotherapy-induced hematotoxicity is influenced by different genes for different chemotherapy drugs.

Indexed as

Genetic BackgroundAnimalsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDocetaxelDoxorubicinFemaleGenetic Predisposition to DiseaseHematologic DiseasesHumansMaleMiceMice, 129 StrainMice, Inbred C57BLMice, Inbred NODAntineoplastic AgentsCyclophosphamideDocetaxelDoxorubicin

Identifiers

PMID28607509
PMCPMC5729066
OpenAlexW2626145662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.